Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 Feb;51(2):178-83.e2.
doi: 10.1016/j.jpainsymman.2015.09.003. Epub 2015 Sep 30.

The Burden of Polypharmacy in Patients Near the End of Life

Michael J McNeil  1 , Arif H Kamal  2 , Jean S Kutner  3 , Christine S Ritchie  4 , Amy P Abernethy  2
Affiliations
Observational Study

The Burden of Polypharmacy in Patients Near the End of Life

Michael J McNeil et al. J Pain Symptom Manage. 2016 Feb.

Abstract

Context: Patients with advanced illness are prescribed multiple medications in the last year of life, intensifying the risk of negative consequences related to polypharmacy.

Objectives: To describe the medication burden of patients near the end of life and identify potential areas for improvement in clinician prescribing practices.

Methods: This was a prespecified secondary analysis of data from a prospective trial. Eligible participants were adults with less than 12 months estimated prognosis taking a statin medication for primary prevention of cardiovascular disease. Participants were enrolled from 15 sites, randomized to continue or discontinue statin medications, and followed for up to a year. Concomitant medications were recorded at least monthly from study enrollment through death. Prescribed medications were categorized by class and subclass. Descriptive statistics were calculated.

Results: On average, participants (n = 244) were 74.3 years old (SD 11.5) and lived 264 days (SD 128); 47.5% of the patients had a primary diagnosis of malignant tumor. This population was exposed to medications across 51 classes, 192 subclasses, and 423 individual medications. Patients took an average of 11.5 (SD 5) medications at the time of enrollment and 10.7 (SD 5) medications at death or study termination. The five most common classes of medications prescribed near the end of life were antihypertensives, broncholytics/bronchodilators, laxatives, antidepressants, and gastric protection agents.

Conclusion: There is a significant medication burden placed on patients with advanced illness. Although most medications were prescribed for supportive care, we observed a high prevalence of medications for managing non-life-threatening comorbidities.

Keywords: Palliative care; end of life; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Medications per patient at baseline.
Fig. 2
Fig. 2
Percentage of patients taking the most common medication classes.
See this image and copyright information in PMC

Comment in

References

    1. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55:590–595. - PubMed
    1. Mamun K, Lien CT, Goh-Tan CY, Ang WS. Polypharmacy and inappropriate medication use in Singapore nursing homes. Ann Acad Med Singapore. 2004;33:49–52. - PubMed
    1. Nauck F, Ostgathe C, Klaschik E, et al. Drugs in palliative care: results from a representative survey in Germany. Palliat Med. 2004;18:100–107. - PubMed
    1. Wilcock A, Thomas J, Frisby J, et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit. Br J Clin Pharmacol. 2005;60:326–329. - PMC - PubMed
    1. Zeppetella G. How do terminally ill patients at home take their medication? Palliat Med. 1999;13:469–475. - PubMed

Publication types

Substances